181 related articles for article (PubMed ID: 3873899)
21. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
Stobberingh EE; Davies BI; van Boven CP
J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
Wallace RJ; Nash DR; Steingrube VA
Am J Med; 1990 May; 88(5A):46S-50S. PubMed ID: 2111092
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.
Sinai R; Hammerberg S; Marks MI; Pai CH
Antimicrob Agents Chemother; 1978 May; 13(5):861-4. PubMed ID: 307367
[TBL] [Abstract][Full Text] [Related]
24. Frequency and type distribution of pneumococcal strains in the Stockholm region with resistance or reduced susceptibility to antibiotics.
Kalin M; Carlsson B; Karlsson I
Scand J Infect Dis; 1984; 16(1):73-8. PubMed ID: 6607514
[TBL] [Abstract][Full Text] [Related]
25. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
26. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
[TBL] [Abstract][Full Text] [Related]
27. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Doern GV; Jorgensen JH; Thornsberry C; Preston DA; Tubert T; Redding JS; Maher LA
Antimicrob Agents Chemother; 1988 Feb; 32(2):180-5. PubMed ID: 3259121
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
Doern GV; Tubert TA
Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
[TBL] [Abstract][Full Text] [Related]
30. In-vitro susceptibility of 400 isolates of Neisseria gonorrhoeae in Vancouver, 1982-84.
Bowie WR; Shaw CE; Chan DG; Jones HD; Black WA
CMAJ; 1986 Sep; 135(5):489-93. PubMed ID: 3091234
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Doern GV; Chapin KC
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
[TBL] [Abstract][Full Text] [Related]
34. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
35. Clinical and Microbiological Aspects of β-Lactam Resistance in Staphylococcus lugdunensis.
McHardy IH; Veltman J; Hindler J; Bruxvoort K; Carvalho MM; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):585-595. PubMed ID: 27927926
[TBL] [Abstract][Full Text] [Related]
36. Pneumonia due to Moraxella (Branhamella) catarrhalis.
Wright PW; Wallace RJ
Semin Respir Infect; 1989 Mar; 4(1):40-6. PubMed ID: 2496450
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents.
Koehler JM; Ashdown LR
Antimicrob Agents Chemother; 1993 Apr; 37(4):905-7. PubMed ID: 8494389
[TBL] [Abstract][Full Text] [Related]
38. Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics.
Ng WS; Anton P; Arnold K
Antimicrob Agents Chemother; 1981 Jan; 19(1):12-7. PubMed ID: 6787976
[TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.
Jones RN; Biedenbach DJ; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):573-8. PubMed ID: 9764398
[TBL] [Abstract][Full Text] [Related]
40. Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.
Strandberg DA; Jorgensen JH; Drutz DJ
Diagn Microbiol Infect Dis; 1984 Sep; 2(4):333-7. PubMed ID: 6333316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
